Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and NeckRobert L. Ferris, Ezra E.W. Cohen, Barbara J. Gitlitz et al.|JAMA Oncology|2018Cited by 111
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck CancerJulie E. Bauman, Christine H. Chung|Journal of Clinical Oncology|2023Cited by 46